Virtual Reality and Standard Care vs. Standard Care Alone for Acute MSK Pain in Geriatric ED Patients
Launched by ANTONIOS LIKOUREZOS · Nov 11, 2024
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using virtual reality (VR) can help reduce pain and anxiety for elderly patients (aged 65 and older) who come to the emergency department with acute musculoskeletal pain, which refers to pain in muscles, bones, or joints. The trial will compare standard pain management practices with standard care plus VR therapy to see if VR can enhance pain relief and improve overall patient satisfaction. Researchers will be looking for nearly 200 eligible patients who have a pain score of 4 or higher and need additional pain relief.
If you or a loved one qualify for this study, you would be randomly assigned to either receive the usual care for pain or to receive the usual care plus a VR experience designed specifically for older adults. Participants will be monitored over two years to assess how well VR works in managing pain and reducing stress in a busy emergency department environment. This study aims to find out if VR can be a helpful tool for elderly patients experiencing pain, leading to better care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age of 65+
- • Emergency Medicine patients
- • non traumatic musculoskeletal painful condition
- • pain score of 4+ on the numeric rating scale
- • patient will warrant parenteral analgesia per treating physician
- • patient will have to be awake, alert, and oriented to person, place, and time.
- • comprehension of informed consent process and study related content
- • ability to complete assessments
- Exclusion Criteria:
- • painful syndrome requiring emergent and/or urgent pain control
- • altered mental status
- • unstable vital signs
- • history of recent epilepsy
- • seizure disorder
- • vertigo
- • active headache
- • nausea
- • motion sickness
- • dizziness
About Antonios Likourezos
Antonios Likourezos is a distinguished clinical trial sponsor renowned for his commitment to advancing medical research and improving patient outcomes. With extensive expertise in clinical development, he leads innovative trials that explore novel therapies and treatment modalities across various therapeutic areas. His strategic approach emphasizes collaboration with healthcare professionals, regulatory bodies, and research institutions, ensuring rigorous adherence to ethical standards and regulatory compliance. Through a patient-centered focus, Antonios Likourezos aims to facilitate the translation of groundbreaking scientific discoveries into effective clinical applications, ultimately contributing to the enhancement of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brooklyn, New York, United States
Patients applied
Trial Officials
Sergey Motov, MD
Principal Investigator
Maimonides Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported